Alfa Wassermann S.p.A.

Reportlinker Adds Ion-Selective Clinical Lab Analyzers - Global Market Opportunities.
PR Newswire; 12/8/2009; 1351 words; ...with Sysmex 6 Beckman Coulter Takes Over Dako's Cytometry Instrumentation Business 6 Beckman...MAJOR PLAYERS 8 Abbott Point of Care (US) 8 Alfa Wassermann S.p.A. (Italy) 8 Alfa Wassermann, Inc. (USA) 8 Beckman Coulter, Inc. (USA...

Salix Pharmaceuticals Gets Intellecutual Property Relating to Rifaximin.
Health & Beauty Close-Up; 11/7/2009; 702 words; ...Pharmaceuticals has announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,612,199 (the...Salix has an exclusive license from Alfa Wassermann, S.p.A., to use, sell, have sold...

Patent No. 7,612,199 Issued on Nov. 3, Assigned to Alfa Wassermann for Polymorphic Form (Italian Inventors)
US Fed News Service, Including US State News; 11/4/2009; 463 words; ...form. The inventors were issued U.S. Patent No. 7,612,199 on Nov. 3. The patent has been assigned to Alfa Wassermann S.p.A., Bologna. According to the abstract released by the U.S. Patent & Trademark Office...

Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to Rifaximin.
Business Wire; 11/3/2009; 1268 words; ...SLXP) today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,612,199 (the...Salix has an exclusive license from Alfa Wassermann, S.p.A., to use, sell, have sold...

Salix Pharmaceuticals Acquires U.S. Right to Lupin's Proprietary Bioadhesive Technology for Extended Release Rifaximin Product.
Journal of India; 10/20/2009; 1661 words; ...rights to market rifaximin in North America from Alfa Wassermann S.p.A. in Bologna, Italy. Alfa Wassermann markets rifaximin in Italy under the trade...treatment of gastrointestinal diseases. Salix's strategy is to in-license late-stage or...